Weight Reduction and Target Serum Urate Level: A Longitudinal Study of Annual Medical Examination

IF 10.9 1区 医学 Q1 RHEUMATOLOGY Arthritis & Rheumatology Pub Date : 2024-10-14 DOI:10.1002/art.43027
Sho Fukui, Masato Okada, Tomohiro Shinozaki, Takahiro Suzuki, Takehiro Nakai, Hiroki Ozawa, Hiromichi Tamaki, Mitsumasa Kishimoto, Hiroshi Hasegawa, Takeaki Matsuda, Javier Marrugo, Sara K. Tedeschi, Hyon K. Choi, Daniel H. Solomon
{"title":"Weight Reduction and Target Serum Urate Level: A Longitudinal Study of Annual Medical Examination","authors":"Sho Fukui,&nbsp;Masato Okada,&nbsp;Tomohiro Shinozaki,&nbsp;Takahiro Suzuki,&nbsp;Takehiro Nakai,&nbsp;Hiroki Ozawa,&nbsp;Hiromichi Tamaki,&nbsp;Mitsumasa Kishimoto,&nbsp;Hiroshi Hasegawa,&nbsp;Takeaki Matsuda,&nbsp;Javier Marrugo,&nbsp;Sara K. Tedeschi,&nbsp;Hyon K. Choi,&nbsp;Daniel H. Solomon","doi":"10.1002/art.43027","DOIUrl":null,"url":null,"abstract":"<div>\n \n <section>\n \n <h3> Objective</h3>\n \n <p>Our objective was to evaluate associations of weight reduction with serum urate (SU) changes and achieving an SU level &lt;6 mg/dL in the real-world setting, outside of specific weight reduction interventions.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>We analyzed systematically collected data of annual medical examination participants from October 2012 to October 2022. Exposure was weight change (increase or decrease) between two consecutive visits, categorized as minimal (≤0.9 kg, reference), small (1.0–4.9 kg), moderate (5.0–9.9 kg), and large (≥10 kg). Outcomes included SU changes between two consecutive visits and achieving an SU level &lt;6 mg/dL in participants with hyperuricemia (SU level ≥7 mg/dL at the previous visit).</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>We identified 58,630 eligible participants (median age 46 years, 51.3% female, 19.4% with overweight, median SU level 5.3 mg/dL, and 5.6% with a history of gout and/or hyperuricemia) with 336,814 visits over a median of 5.3 years. After adjustment for relevant covariates, linear general estimating equations estimated mean SU changes based on observed weight reductions (vs minimal changes) were as follows: small, −0.10 mg/dL (95% confidence interval [CI] −0.10 to −0.09 mg/dL); moderate, −0.34 mg/dL (95% CI −0.36 to −0.32 mg/dL); and large, −0.64 (95% CI −0.70 to −0.58 mg/dL). In participants with hyperuricemia, adjusted relative risks for achieving an SU level &lt;6 mg/dL by modified Poisson regression were 1.25 (95% CI 1.15–1.37) in small weight reductions, 2.82 (95% CI 2.43–3.27) in moderate weight reductions, and 5.27 (95% CI 4.15–6.70) in large weight reductions, with corresponding numbers needed to treat of 61.1 for small weight reductions, 8.5 for moderate weight reductions, and 3.6 for large weight reductions.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Small weight reductions were associated with only small SU changes. Some participants with hyperuricemia can achieve the target SU level with moderate to large weight reductions.</p>\n \n <div>\n <figure>\n <div><picture>\n <source></source></picture><p></p>\n </div>\n </figure>\n </div>\n </section>\n </div>","PeriodicalId":129,"journal":{"name":"Arthritis & Rheumatology","volume":"77 3","pages":"346-355"},"PeriodicalIF":10.9000,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Arthritis & Rheumatology","FirstCategoryId":"3","ListUrlMain":"https://acrjournals.onlinelibrary.wiley.com/doi/10.1002/art.43027","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

Our objective was to evaluate associations of weight reduction with serum urate (SU) changes and achieving an SU level <6 mg/dL in the real-world setting, outside of specific weight reduction interventions.

Methods

We analyzed systematically collected data of annual medical examination participants from October 2012 to October 2022. Exposure was weight change (increase or decrease) between two consecutive visits, categorized as minimal (≤0.9 kg, reference), small (1.0–4.9 kg), moderate (5.0–9.9 kg), and large (≥10 kg). Outcomes included SU changes between two consecutive visits and achieving an SU level <6 mg/dL in participants with hyperuricemia (SU level ≥7 mg/dL at the previous visit).

Results

We identified 58,630 eligible participants (median age 46 years, 51.3% female, 19.4% with overweight, median SU level 5.3 mg/dL, and 5.6% with a history of gout and/or hyperuricemia) with 336,814 visits over a median of 5.3 years. After adjustment for relevant covariates, linear general estimating equations estimated mean SU changes based on observed weight reductions (vs minimal changes) were as follows: small, −0.10 mg/dL (95% confidence interval [CI] −0.10 to −0.09 mg/dL); moderate, −0.34 mg/dL (95% CI −0.36 to −0.32 mg/dL); and large, −0.64 (95% CI −0.70 to −0.58 mg/dL). In participants with hyperuricemia, adjusted relative risks for achieving an SU level <6 mg/dL by modified Poisson regression were 1.25 (95% CI 1.15–1.37) in small weight reductions, 2.82 (95% CI 2.43–3.27) in moderate weight reductions, and 5.27 (95% CI 4.15–6.70) in large weight reductions, with corresponding numbers needed to treat of 61.1 for small weight reductions, 8.5 for moderate weight reductions, and 3.6 for large weight reductions.

Conclusion

Small weight reductions were associated with only small SU changes. Some participants with hyperuricemia can achieve the target SU level with moderate to large weight reductions.

Abstract Image

Abstract Image

Abstract Image

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
减轻体重与目标血清尿酸水平:年度体检纵向研究
目的:在实际环境中,评估减轻体重与血清尿酸盐(SU)变化之间的关系,以及在不采取特定减轻体重干预措施的情况下,实现 SU <6 mg/dl 的目标。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Arthritis & Rheumatology
Arthritis & Rheumatology RHEUMATOLOGY-
CiteScore
20.90
自引率
3.00%
发文量
371
期刊介绍: Arthritis & Rheumatology is the official journal of the American College of Rheumatology and focuses on the natural history, pathophysiology, treatment, and outcome of rheumatic diseases. It is a peer-reviewed publication that aims to provide the highest quality basic and clinical research in this field. The journal covers a wide range of investigative areas and also includes review articles, editorials, and educational material for researchers and clinicians. Being recognized as a leading research journal in rheumatology, Arthritis & Rheumatology serves the global community of rheumatology investigators and clinicians.
期刊最新文献
Identifying systemic lupus erythematosus from serum proteomic profiles using machine learning and genetic risk stratification Reply. Combination Therapy in Participants With Active Psoriatic Arthritis Using Subcutaneous Guselkumab and Golimumab: Week 24 Results From the Phase 2a, Multicenter, Randomized, Double-Blind, Proof-of-Concept AFFINITY Study Per- and polyfluoroalkyl substances and knee osteoarthritis: data from the Osteoarthritis Initiative Commentary on: “Nationwide temporal trends in adverse pregnancy outcomes and treatments in systemic lupus erythematosus pregnancy over two decades in Sweden”
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1